![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: John Wiley & Sons Inc
E-ISSN: 2160-7648|5|2|91-101
ISSN: 2160-763X
Source: Clinical Pharmacology In Drug Development, Vol.5, Iss.2, 2016-03, pp. : 91-101
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Staab A. Schug B.S. Larsimont V. Elze M. Thummler D. Mutschler E. Blume H.
European Journal of Pharmaceutical Sciences, Vol. 18, Iss. 2, 2003-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Clinical Drug Investigation, Vol. 32, Iss. 4, 2012-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Galectins: novel anti-inflammatory drug targets
By Liu Fu-Tong
Expert Opinion on Therapeutic Targets, Vol. 6, Iss. 4, 2002-08 ,pp. :